We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

LeukoDx, GE Healthcare Enter Agreement

News   Mar 26, 2016

 
LeukoDx, GE Healthcare Enter Agreement
 
 
Advertisement
 

RELATED ARTICLES

Dual CAR T Cell Immunotherapy Fights HIV Infection in Humanized Mice

News

A recent study published in the journal Nature Medicine describes a new Dual CAR T cell immunotherapy that can help fight HIV infection.

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

Convalescent Plasma Appears Safe and Possibly Effective in Pediatric Patients With Severe COVID-19

News

Early findings from a small study indicate that convalescent plasma appears to be safe and possibly effective as a treatment for children with life-threatening cases of COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE